Literature DB >> 11510965

Expression of clusterin in Crohn's disease of the terminal ileum.

N Gassler1, F Autschbach, G Heuschen, R Witzgall, H F Otto, N Obermüller.   

Abstract

Crohn's disease (CD) is a chronic inflammatory intestinal disorder with disturbance and injury of the intestinal mucosal barrier, in which various proinflammatory molecules as well as molecules with antiinflammatory activity and cytoprotective function are found to be expressed. We investigated whether clusterin, a multifunctional cytoprotective protein, is upregulated in Crohn's disease, because augmented expression of clusterin is seen in many organs following various forms of tissue injury. Human actively and inactively inflamed ileal tissues from CD patients as well as normal intestinal specimens from control patients (normal ileum) were investigated by Western blot analysis, immunohistochemisty and in situ hybridization. As compared with controls, a strongly enhanced expression of clusterin was found in CD tissues, correlating with disease activity. Immunohistochemistry and in situ hybridization analysis revealed foci of crypts almost completely lined by clusterin expressing enterocytes in CD, a feature that was never seen in controls. Such crypts appeared especially within the morphologically intact mucosa apart from erosive or ulcerative lesions. Besides epithelia, clusterin was also expressed by inflammatory mononuclear cells. Enhanced expression of clusterin by crypt epithelia might reflect a cytoprotective function of the protein in order to prevent further injury of the intestinal mucosal barrier in CD.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11510965     DOI: 10.14670/HH-16.755

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  6 in total

1.  Induction of intestinal inflammation in mouse by activation of proteinase-activated receptor-2.

Authors:  Nicolas Cenac; Anne-Marie Coelho; Cathy Nguyen; Steven Compton; Patricia Andrade-Gordon; Wallace K MacNaughton; John L Wallace; Morley D Hollenberg; Nigel W Bunnett; Rafael Garcia-Villar; Lionel Bueno; Nathalie Vergnolle
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

2.  Serum protein profiling of adults and children with Crohn disease.

Authors:  Anna Vaiopoulou; Maria Gazouli; Aggeliki Papadopoulou; Athanassios K Anagnostopoulos; George Karamanolis; George E Theodoropoulos; Amosy M'Koma; George T Tsangaris
Journal:  J Pediatr Gastroenterol Nutr       Date:  2015-01       Impact factor: 2.839

3.  miR-130a and miR-212 Disrupt the Intestinal Epithelial Barrier through Modulation of PPARγ and Occludin Expression in Chronic Simian Immunodeficiency Virus-Infected Rhesus Macaques.

Authors:  Vinay Kumar; Joshua Mansfield; Rong Fan; Andrew MacLean; Jian Li; Mahesh Mohan
Journal:  J Immunol       Date:  2018-03-07       Impact factor: 5.422

4.  Clusterin in human gut-associated lymphoid tissue, tonsils, and adenoids: localization to M cells and follicular dendritic cells.

Authors:  Phebe Verbrugghe; Pekka Kujala; Wim Waelput; Peter J Peters; Claude A Cuvelier
Journal:  Histochem Cell Biol       Date:  2007-12-21       Impact factor: 4.304

5.  Diverse functions of clusterin promote and protect against the development of pulmonary fibrosis.

Authors:  Lizzy Peix; Iona C Evans; David R Pearce; Juliet K Simpson; Toby M Maher; Robin J McAnulty
Journal:  Sci Rep       Date:  2018-01-30       Impact factor: 4.379

6.  Clusterin serum levels are elevated in patients with early rheumatoid arthritis and predict disease activity and treatment response.

Authors:  Tereza Kropáčková; Heřman Mann; Olga Růžičková; Olga Šléglová; Lucia Vernerová; Veronika Horváthová; Michal Tomčík; Karel Pavelka; Jiří Vencovský; Ladislav Šenolt
Journal:  Sci Rep       Date:  2021-06-01       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.